THE ROLE OF MOLECULAR BIOLOGICAL AND IMMUNOLOGICAL MARKERS IN THE DIAGNOSIS AND TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANCER

Abstract

It has been established that small-sized circulating immune complexes have great pathological potential, while a high level of small circulating immune complexes shows an active fight of immunity against virus antigens, on the one hand, and on the other hand, is associated with a violation of the mechanisms of virus elimination, which plays a significant role in the formation and maintaining the malignant process. All this contributes to the violation of immune regulation, triggering the mechanisms of carcinogenesis with the development of the disease. Thus, the combined determination of the level of VEGF, the CD95+ apoptosis marker, and the IRI immunoregulation index in complex clinical cases improves the diagnosis of OPR and allows timely prediction of a more severe course of oropharyngeal cancer to avoid unnecessary biopsies or sectoral resections.